In vitro tumor killing effect of CIK cells in cord blood on drug-resistant leukemia cells and its mechanism
Song Shanjun
Abstract
Song Shanjun
Abstract
Objective:To explore the new strategy of intervening and overcoming multi-drug resistance(MDR)of leukemia cells.Method:The killer cells in cord blood(CB-CIK)were induced by CD3 monoclonal antibody(CD3McAb)combined with multi-cytokines,and subsequently used to kill drug-resistant leukemia cells(K562/A02)in vitro.Cytotoxic effect was detected by MTT colourimetry.Expression of P-glycoprotein(P170)on surface of K562/A02 cells was tested by immuno-histochemical dyeing method.Apoptosis of K562/A02 cells was measured by DNA gel electrophoresis.Result:① Cytotoxic effect of CB-CIK cells on K562/A02cells was not statistically different from that on K562 cells.Tumor-killing effect of CB-CIK cells on K562/A02 cells was significantly higher than that on CB-LAK cells and CB-CD3AK cells(P0.05).But no significant difference in tumor-killing effect was found between CB-CIK group and PB-CIK group(P0.05).② After treated with CB-CIK cells,expression of P170 on surface of K562/A02 cells reduced obviously.③After 20 hours co-culturing with CB-CIK cells and K562/A02 cells,apoptotic K562/A02 cells displayed clear DNA ladder band on DNA gel electrophoresis.Conclusion:Tumor-killing effect of CB-CIK cells on K562/A02 cells was as efficient as that on K562.The tumor-killing mechanism of CB-CIK cells may be decrease of expression of P170 and induce of apoptosis in leukemia cells.Therefore combination of CB-CIK cells with chemotherapy might be one of new strategy for overcoming MDR in leukemia cells.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the new strategy of intervening and overcoming multi-drug resistance(MDR)of leukemia cells.Method:The killer cells in cord blood(CB-CIK)were induced by CD3 monoclonal antibody(CD3McAb)combined with multi-cytokines,and subsequently used to kill drug-resistant leukemia cells(K562/A02)in vitro.Cytotoxic effect was detected by MTT colourimetry.Expression of P-glycoprotein(P170)on surface of K562/A02 cells was tested by immuno-histochemical dyeing method.Apoptosis of K562/A02 cells was measured by DNA gel electrophoresis.Result:① Cytotoxic effect of CB-CIK cells on K562/A02cells was not statistically different from that on K562 cells.Tumor-killing effect of CB-CIK cells on K562/A02 cells was significantly higher than that on CB-LAK cells and CB-CD3AK cells(P0.05).But no significant difference in tumor-killing effect was found between CB-CIK group and PB-CIK group(P0.05).② After treated with CB-CIK cells,expression of P170 on surface of K562/A02 cells reduced obviously.③After 20 hours co-culturing with CB-CIK cells and K562/A02 cells,apoptotic K562/A02 cells displayed clear DNA ladder band on DNA gel electrophoresis.Conclusion:Tumor-killing effect of CB-CIK cells on K562/A02 cells was as efficient as that on K562.The tumor-killing mechanism of CB-CIK cells may be decrease of expression of P170 and induce of apoptosis in leukemia cells.Therefore combination of CB-CIK cells with chemotherapy might be one of new strategy for overcoming MDR in leukemia cells.
Key concepts: K562 cells, Cytotoxic T cell, Leukemia, Molecular biology, Apoptosis, Cancer research, Biology, Cord blood